90 filings
Page 3 of 5
8-K
7tocu4q9pgvyxs1c
20 May 21
Departure of Directors or Certain Officers
5:00pm
8-K
wgii qaiur6
10 May 21
Codiak Appoints Jennifer Wheler, M.D., as Chief Medical Officer
5:18pm
8-K
gh2pjmkj
6 May 21
Codiak BioSciences Reports First Quarter 2021 Financial Results and Operational Progress
4:10pm
DEFA14A
xrsb9ranhndltzpk
30 Apr 21
Additional proxy soliciting materials
4:26pm
DEF 14A
4vr5ix0
30 Apr 21
Definitive proxy
4:23pm
8-K
rm8sisdeclw 1vt82dw
8 Apr 21
Regulation FD Disclosure
4:05pm
8-K
cp5hxinsp a9i
26 Mar 21
Departure of Directors or Certain Officers
4:05pm
S-8
hgym8
17 Mar 21
Registration of securities for employees
4:41pm
10-K
ojkvt4
17 Mar 21
Annual report
4:15pm
8-K
lvyl7
17 Mar 21
Codiak BioSciences Reports Fourth Quarter and Full Year 2020 Financial Results
7:44am
8-K
v0irh
8 Mar 21
Departure of Directors or Certain Officers
5:18pm
424B4
bphp15f fx60m
12 Feb 21
Prospectus supplement with pricing info
4:02pm
EFFECT
gpeixywszj9k
12 Feb 21
Notice of effectiveness
12:15am
S-1MEF
3qjtwab m95m
11 Feb 21
Registration of additional securities for an S-1
9:19pm
CORRESP
bslm 1zyf
9 Feb 21
Correspondence with SEC
12:00am
CORRESP
qudne
9 Feb 21
Correspondence with SEC
12:00am
8-K
ja18m8866gi940l
4 Feb 21
Codiak Reports Additional Positive Phase 1 Results for exoIL-12™ Confirming
8:46am
8-K
nym1mbgqvk wo2c0bk6
26 Jan 21
Departure of Directors or Certain Officers
4:39pm